The indoleamine 2,3-dioxygenase (IDO) pathway controls allergyVON BUBNOFF, D; BIEBER, T.Allergy (Copenhagen). 2012, Vol 67, Num 6, pp 718-725, issn 0105-4538, 8 p.Article

The central role of FcεRI in allergyVON BUBNOFF, D; NOVAK, N; KRAFT, S et al.Clinical and experimental dermatology (Print). 2003, Vol 28, Num 2, pp 184-187, issn 0307-6938, 4 p.Article

Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposureVON BUBNOFF, D; FIMMERS, R; BOGDANOW, M et al.Clinical and experimental allergy (Print). 2004, Vol 34, Num 7, pp 1056-1063, issn 0954-7894, 8 p.Article

Comparative immunophenotyping of monocytes from symptomatic and asymptomatic atopic individualsVON BUBNOFF, D; SCHELER, M; HINZ, T et al.Allergy (Copenhagen). 2004, Vol 59, Num 9, pp 933-939, issn 0105-4538, 7 p.Article

Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE, FcεRI and interferon-γ stimulationVON BUBNOFF, D; BEZOLD, G; MATZ, H et al.Clinical and experimental immunology (Print). 2003, Vol 132, Num 2, pp 247-253, issn 0009-9104, 7 p.Article

Antigen-presenting cells and tolerance inductionVON BUBNOFF, D; DE LA SALLE, H; WESSENDORF, J et al.Allergy (Copenhagen). 2002, Vol 57, Num 1, pp 2-8, issn 0105-4538Article

Differential Expression of Toll-Like Receptor 2 on Dendritic Cells from Asymptomatic and Symptomatic Atopic DonorsBUBNOFF, D. Von; SELL, U; ARRIENS, S et al.International archives of allergy and immunology. 2012, Vol 159, Num 1, pp 41-50, issn 1018-2438, 10 p.Article